i-STAT to go it alone after Abbott deal ends
This article was originally published in Clinica
Executive Summary
Diagnostic company i-STAT is to resume direct distribution of its products from January 1 2004, the day after its five-year exclusive pact with Abbott comes to an end. The company is choosing not to continue its distribution deal for its blood analysis products with the larger company and will be obliged to pay Abbott around $70m over several years.